In:
Blood, American Society of Hematology, Vol. 127, No. 25 ( 2016-06-23), p. 3281-3290
Abstract:
Donor chimerism 〉 20%-30% usually protects against late disease reactivation after day 180 post stem cell transplantation for primary HLH. Lower levels do not inevitably result in reactivations. The risks of intervention must be weighed against the risk of reactivation.
Type of Medium:
Online Resource
ISSN:
0006-4971
,
1528-0020
DOI:
10.1182/blood-2015-12-684498
Language:
English
Publisher:
American Society of Hematology
Publication Date:
2016
detail.hit.zdb_id:
1468538-3
detail.hit.zdb_id:
80069-7